Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed 2024 […]
First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed 2024 […]
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment in the second quarter of 2024. Ended the […]
Revenue of $36.9 million and net loss per share of $(0.40) – both above the high end of their respective […]
TORONTO, May 02, 2024 (GLOBE NEWSWIRE) — Not for distribution to U.S. newswire services or for dissemination in the United […]
FREMONT, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (NASDAQ: CSLR) today announced […]
ST. JOHN’S, Newfoundland and Labrador, May 02, 2024 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS) announced […]
FREMONT, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR) today published […]
WEST DES MOINES, Iowa, May 02, 2024 (GLOBE NEWSWIRE) — Athene USA (“Athene”), a leading provider of retirement savings products, […]
– Filing reflects Company’s belief that Verano’s defense against claims of unlawful conduct is without merit – – Legal filing […]
BETHESDA, Md., May 02, 2024 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the parent company of EagleBank, […]